Skip to main content
Premium Trial:

Request an Annual Quote

Chinese Agency Clears BGI-Complete Genomics Deal

NEW YORK (GenomeWeb News) – The Ministry of Commerce of the People's Republic of China has approved BGI's proposed acquisition of Complete Genomics, BGI announced after the close of the market on Monday.

The $118 million deal is still awaiting approval by the China's State Administration of Foreign Exchange. BGI last week extended its cash tender offer for Complete Genomics until midnight ET March 1, as it waited for approval from the two agencies.

BGI's bid for the Mountain View, Calif.-based firm was originally announced in September. The deal cleared US antitrust review in early January.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.